NasdaqCM:SLNOBiotechs
A Look At Soleno Therapeutics (SLNO) Valuation After Recent Share Momentum And VYKAT XR Launch Progress
Soleno Therapeutics stock overview
Soleno Therapeutics (SLNO) has drawn investor attention after recent share performance, with the stock showing a one-month return of 34.01% and a three-month return of 25.64%.
See our latest analysis for Soleno Therapeutics.
That recent momentum sits against a mixed longer record, with a 34.01% 1 month share price return and 25.64% 3 month share price return contrasting with a 28.21% 1 year total shareholder return decline but a very large 3 year total...

